Literature DB >> 11181510

Effect of hypothyroidism on G protein-coupled receptor kinase 2 expression levels in rat liver, lung, and heart.

P Penela1, M Barradas, M Alvarez-Dolado, A Muñoz, F Mayor.   

Abstract

GRK2 is a member of the G protein-coupled receptor kinase family that phosphorylates the activated form of beta-adrenergic and other G protein-coupled receptors and plays an important role in their desensitization and modulation. Alterations in thyroid hormone levels have been reported to lead to important changes in adrenergic receptor responsiveness and signaling in a variety of tissues. In this context, we have explored the effects of experimental hypothyroidism on GRK2 protein levels in rat heart, lung, and liver using a specific antibody. Hypothyroid animals show significant up-regulation ( approximately 50% increase compared with controls) in GRK2 levels in heart and lung at 60 days after birth, whereas a 50% reduction is detected in the liver at this stage. These alterations are selective, as beta-adrenergic receptors or other G protein-coupled receptor regulatory proteins, such as G protein-coupled receptor kinase 5 or beta-arrestin-1, display a different pattern of expression changes in the hypothyroid animals. The reported changes in GRK2 levels and in the receptor/kinase ratio predict alterations in adrenergic receptor desensitization and signal transduction efficacy consistent with those observed in thyroid disorders, thus suggesting a relevant role for the modulation of GRK2 expression in this physiopathological condition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181510     DOI: 10.1210/endo.142.3.8039

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

Review 1.  Endocannabinoids and the Endocrine System in Health and Disease.

Authors:  Cecilia J Hillard
Journal:  Handb Exp Pharmacol       Date:  2015

2.  Pulmonary hypertension and Hashimoto's thyroiditis: does a relationship exist?

Authors:  Marco Matteo Ciccone; Annapaola Zito; Anna Ciampolillo; Michele Gesualdo; Pierluigi Zaza; Marica Rodio; Mariapaola Barbaro; Sergio Di Molfetta; Pietro Scicchitano
Journal:  Endocrine       Date:  2014-07-25       Impact factor: 3.633

3.  Beta-arrestin- and c-Src-dependent degradation of G-protein-coupled receptor kinase 2.

Authors:  P Penela; A Elorza; S Sarnago; F Mayor
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

4.  Multiple scaffolding functions of {beta}-arrestins in the degradation of G protein-coupled receptor kinase 2.

Authors:  Laura Nogués; Alicia Salcedo; Federico Mayor; Petronila Penela
Journal:  J Biol Chem       Date:  2010-11-16       Impact factor: 5.157

5.  The changes in beta-adrenoceptor-mediated cardiac function in experimental hypothyroidism: the possible contribution of cardiac beta3-adrenoceptors.

Authors:  E Arioglu; S Guner; I Ozakca; V M Altan; A T Ozcelikay
Journal:  Mol Cell Biochem       Date:  2009-09-01       Impact factor: 3.396

Review 6.  GRK5 Deficiency Causes Mild Cognitive Impairment due to Alzheimer's Disease.

Authors:  William Z Suo
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 7.  β-Arrestin Based Receptor Signaling Paradigms: Potential Therapeutic Targets for Complex Age-Related Disorders.

Authors:  Jaana van Gastel; Jhana O Hendrickx; Hanne Leysen; Paula Santos-Otte; Louis M Luttrell; Bronwen Martin; Stuart Maudsley
Journal:  Front Pharmacol       Date:  2018-11-28       Impact factor: 5.810

8.  Sex Differences in High Fat Diet-Induced Metabolic Alterations Correlate with Changes in the Modulation of GRK2 Levels.

Authors:  Alba C Arcones; Marta Cruces-Sande; Paula Ramos; Federico Mayor; Cristina Murga
Journal:  Cells       Date:  2019-11-19       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.